- Home
- SMXT vs ENLV Comparison
SMXT vs ENLV Comparison
Compare SMXT & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMXT
- ENLV
- Stock Information
- Founded
- SMXT 2008
- ENLV 2005
- Country
- SMXT United States
- ENLV Israel
- Employees
- SMXT N/A
- ENLV N/A
- Industry
- SMXT
- ENLV Biotechnology: Pharmaceutical Preparations
- Sector
- SMXT
- ENLV Health Care
- Exchange
- SMXT NYSE
- ENLV Nasdaq
- Market Cap
- SMXT 27.9M
- ENLV 31.5M
- IPO Year
- SMXT 2024
- ENLV 1995
- Fundamental
- Price
- SMXT $1.04
- ENLV $1.09
- Analyst Decision
- SMXT
- ENLV Strong Buy
- Analyst Count
- SMXT 0
- ENLV 2
- Target Price
- SMXT N/A
- ENLV $9.50
- AVG Volume (30 Days)
- SMXT 119.8K
- ENLV 173.7K
- Earning Date
- SMXT 11-19-2024
- ENLV 11-30-2024
- Dividend Yield
- SMXT N/A
- ENLV N/A
- EPS Growth
- SMXT N/A
- ENLV N/A
- EPS
- SMXT N/A
- ENLV N/A
- Revenue
- SMXT $36,735,765.00
- ENLV N/A
- Revenue This Year
- SMXT N/A
- ENLV N/A
- Revenue Next Year
- SMXT N/A
- ENLV N/A
- P/E Ratio
- SMXT N/A
- ENLV N/A
- Revenue Growth
- SMXT N/A
- ENLV N/A
- 52 Week Low
- SMXT $0.60
- ENLV $1.08
- 52 Week High
- SMXT $15.88
- ENLV $4.59
- Technical
- Relative Strength Index (RSI)
- SMXT N/A
- ENLV 27.79
- Support Level
- SMXT N/A
- ENLV $1.13
- Resistance Level
- SMXT N/A
- ENLV $1.33
- Average True Range (ATR)
- SMXT 0.00
- ENLV 0.10
- MACD
- SMXT 0.00
- ENLV -0.02
- Stochastic Oscillator
- SMXT 0.00
- ENLV 6.52
About SMXT SOLARMAX TECHNOLOGY INC
SolarMax Technology Inc is an integrated solar and renewable energy company. It operates in two segments namely the United States and China. The United States business includes the sale and installation of photovoltaic and battery backup systems. China operations consist of operating and maintaining solar farm projects and identifying and procuring solar farm projects for resale to third parties. Some of its products are LG Solar Panels, QCELL Solar Panels, Panasonic Solar Panels, and others. The company generates a majority of its revenue from the Solar energy systems.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.